Home Merck KGaA's (MKGAY) "Neutral" Rating Reaffirmed at Goldman Sachs
 

Keywords :   


Merck KGaA's (MKGAY) "Neutral" Rating Reaffirmed at Goldman Sachs

2016-02-06 15:04:08| Biotech - Topix.net

's stock had its "neutral" rating reissued by research analysts at Goldman Sachs in a note issued to investors on Saturday, AnalystRatings.Net reports. They currently have a $56.00 target price on the stock, down from their previous target price of $60.00.

Tags: rating neutral goldman sachs

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
18.06Potential Tropical Cyclone One Graphics
18.06Potential Tropical Cyclone One Public Advisory Number 3A
18.06Summary for Potential Tropical Cyclone One (AT1/AL012024)
18.06Post Office sabotaged Horizon probe, says investigator
18.06Atlantic Tropical Weather Outlook
18.06Eastern North Pacific Tropical Weather Outlook
18.06Farm Progress America, June 18, 2024
18.06Farm Progress America, June 18, 2024
More »